Acute myeloid leukemia of mixed megakaryocytic and erythroid origin following chemotherapy for T-cell lymphoblastic lymphoma

Int J Hematol. 2014 Mar;99(3):213-4. doi: 10.1007/s12185-014-1512-3. Epub 2014 Feb 1.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Asparaginase / administration & dosage
  • Cytarabine / administration & dosage
  • Daunorubicin / administration & dosage
  • Dexamethasone / administration & dosage
  • Erythroid Cells / pathology*
  • Humans
  • Idarubicin / administration & dosage
  • Induction Chemotherapy
  • Leukemia, Myeloid, Acute / pathology*
  • Male
  • Mediastinal Neoplasms / drug therapy*
  • Mediastinal Neoplasms / pathology*
  • Megakaryocytes / pathology*
  • Mitoxantrone / administration & dosage
  • Neoplasms, Second Primary*
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / pathology*
  • Remission Induction
  • Vincristine / administration & dosage

Substances

  • Cytarabine
  • Vincristine
  • Dexamethasone
  • Mitoxantrone
  • Asparaginase
  • Idarubicin
  • Daunorubicin